Management of late-stage parapneumonic empyema

https://doi.org/10.1053/jpsu.2002.30828Get rights and content

Abstract

Purpose: Despite the reported value of early video-assisted thoracoscopic surgery (VATS) for empyema, many children are still referred to the surgeon late in the disease process. The authors wished to determine the optimal management strategy for this group of children. Methods: Medical records of all children (n = 70) from 1990 to 2000 with late-presenting empyema (stage II or III) were reviewed. Patients were grouped as (G1) successful management with chest tube (CT), (G2) surgery after initial CT, (G3) thoracentesis followed by surgery, and (G4) surgery alone. Results: There were no significant differences with respect to age, gender, pleural cultures or fluid analysis. Fifty-one (73%) patients required surgical intervention. Treatment using CT (G1, G2) or thoracentesis (G3) was associated with prolonged length of stay (LOS) when compared with surgery alone (G4; 12 v 8 days). For G2, G3, and G4, rapid clinical improvement and early discharge (6 days) was seen after surgery. For all surgery groups (G2, G3, G4), video-assisted thoracoscopic surgery (n = 19) was associated with a longer postoperative fever (4 v 2 days; P [lt ] .05), but a shorter total LOS (12 v 15 days; P [lt ] .05) when compared with open decortication (n = 32). Conclusions: Over 70% of children with late presenting empyema required surgery, including more than half of the children who received initial chest tube drainage. Delay in surgery was associated with more procedures, more radiographs, and an increased LOS. Despite later intervention, patients undergoing surgery as an initial approach had the shortest length of stay. Early surgical intervention is indicated for most children referred with established empyema.

References (0)

Cited by (57)

  • The role of tissue plasminogen activator in the management of complex intra-abdominal abscesses in children

    2012, Journal of Pediatric Surgery
    Citation Excerpt :

    Fibrinolytic therapy has been used extensively for the treatment of loculated empyema in both adults and children [13-15]. Although surgical management of complex empyema by thoracotomy or video-assisted thoracic surgery has been advocated by many authors [44,52], recent studies have shown that the use of fibrinolytic agents through a small chest tube is as effective as surgical intervention [14,45,53]. This study represents the largest series of patients undergoing fibrinolytic therapy reported to date and is the only one in children.

  • Pediatric Chest I. Developmental and Physiologic Conditions for the Surgeon

    2012, Surgical Clinics of North America
    Citation Excerpt :

    It is believed that this strategy leads to a faster, more complete evacuation of the chest, a faster resolution of symptoms, and a decreased length of stay compared with other interventions. In addition, it may prevent multiple procedures in the case of failed initial therapy with thoracentesis or thoracostomy with or without fibrinolysis.57,71–79 Others believe that thoracostomy with fibrinolysis, using agents such as streptokinase, urokinase, or tissue plasminogen activator, is as effective as VATS drainage in most cases, and that it may be more cost-effective with less morbidity than VATS.52,57,79–81

  • Air and Liquid in the Pleural Space

    2012, Kendig and Chernick's Disorders of the Respiratory Tract in Children
  • Video-Assisted Thoracoscopic Surgery

    2010, Medical Management of the Thoracic Surgery Patient
  • Surgical thoracoscopy in children

    2007, Archives de Pediatrie
View all citing articles on Scopus
View full text